Post-treatment dopexamine infusions partially reverse reductions in cranial mesenteric blood flow and mucosal oxygenation induced by hypoxia in newborn piglets
S. Aliabadi-wahle et al., Post-treatment dopexamine infusions partially reverse reductions in cranial mesenteric blood flow and mucosal oxygenation induced by hypoxia in newborn piglets, AM SURG, 65(6), 1999, pp. 548-553
A severe hypoxic insult is known to induce dramatic reductions in newborn i
ntestinal blood flow and is, thus, considered a vector for the development
of neonatal intestinal ischemic diseases. Dopexamine (DPX) is a novel synth
etic agent that has potent B-2-adrenoceptor and dopaminergic activity, the
clinical effects of which include an increase in cardiac output and in mese
nteric blood now. Having previously shown that infusion of DPX before hypox
ia (HYP) mitigated the reduction in newborn mesenteric blood flow, we sough
t to define its efficacy when given after an established hypoxic insult. Ul
trasonic transit time blood flow probes were placed around the ascending ao
rta and cranial mesenteric artery of anesthetized, mechanically ventilated
0 to 2-day-old piglets. Small bowel mucosal oxygenation was observed with a
tissue oxygen monitoring system. After stabilization, animals were subject
ed to one of the following: HYP (FIO2 = 0.12) for 60 minutes (n = 12); DPX
(5 mu g/kg/min) infusion begun 10 minutes after induction of HYP/DPX (n = 1
1). Almost no alterations in any of the monitored variables were shown in a
group (n = 5) of similarly instrumented, untreated animals. In contrast, a
lthough both hypoxic piglet groups experienced significant (P < 0.05, analy
sis of variance) declines from baseline cardiac output, mesenteric blood fl
ow, and mucosal oxygenation, each of these deleterious effects was signific
antly (P < 0.05) blunted in the DPX-treated animals. During periods of syst
emic hypoxemia, the reductions in neonatal mesenteric blood flow and oxygen
ation can be somewhat blunted by DPX. As such, this agent may prove of clin
ical benefit when an infant is threatened by a hypoxic episode.